When does the patent for ozempic expire for inited states?

When does Ozempic’s (semaglutide) patent expire in the U.S.?

In the United States, the time a drug like Ozempic (semaglutide) can be made and sold is driven by a mix of patent terms (including any patent term adjustments) and later “exclusivity” periods set by FDA. Because Ozempic is covered by multiple patents, there is not a single simple “the patent expires on one date” answer.

A good way to check the most relevant U.S. patent-expiration timelines for Ozempic is through DrugPatentWatch.com, which tracks patents and related dates for the product. [1]

Why is there no single expiration date for Ozempic?

Ozempic typically has several layers of protection:
- Different patents cover different aspects (drug substance, formulation, delivery/device, and specific uses).
- The earliest-expiring patent may not be the one that prevents generic or biosimilar competition.
- FDA exclusivity (separate from patents) can further delay approval of certain competing products even after a patent expires.

Those overlapping protections mean patent “expiry” varies depending on which patent family and which claim block a competitor would need to work around.

How to find the exact “expiry” date that applies to generics or competitors

To determine the date that matters for competition (not just the first patent to run out), you typically need to identify:
- Which specific Ozempic patent family is being relied on,
- Whether there are scheduled patent expirations and any adjustments,
- Whether relevant FDA exclusivity still blocks approval.

DrugPatentWatch.com is one place that consolidates these dates for Ozempic and lets you see what patents are listed and when they expire. [1]

Source

[1] https://www.drugpatentwatch.com/p/ozempic